Automate Your Wheel Strategy on ILMN
With Tiblio's Option Bot, you can configure your own wheel strategy including ILMN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ILMN
- Rev/Share 27.2767
- Book/Share 14.8931
- PB 6.5426
- Debt/Equity 1.1009
- CurrentRatio 1.8562
- ROIC 0.3203
- MktCap 15424752000.0
- FreeCF/Share 5.4654
- PFCF 17.75
- PE -16.0549
- Debt/Assets 0.4217
- DivYield 0
- ROE -0.4649
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | ILMN | Citigroup | -- | Neutral | $130 | $90 | March 4, 2025 |
| Downgrade | ILMN | HSBC Securities | Buy | Hold | -- | $100 | Feb. 28, 2025 |
| Downgrade | ILMN | Barclays | Equal Weight | Underweight | $130 | $100 | Feb. 10, 2025 |
| Downgrade | ILMN | TD Cowen | Buy | Hold | $177 | $140 | Feb. 7, 2025 |
| Downgrade | ILMN | Citigroup | Buy | Neutral | $190 | $165 | Dec. 11, 2024 |
| Upgrade | ILMN | HSBC Securities | Hold | Buy | -- | $180 | Oct. 17, 2024 |
| Upgrade | ILMN | Argus | Hold | Buy | -- | -- | Aug. 28, 2024 |
| Upgrade | ILMN | Daiwa Securities | Neutral | Buy | $120 | $154 | Aug. 16, 2024 |
News
Here's Why Illumina (ILMN) is a Strong Growth Stock
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
ILMN vs. ALNY: Which Stock Is the Better Value Option?
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Illumina (ILMN) and Alnylam Pharmaceuticals (ALNY). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Why Illumina Stock Got Mashed on Monday
Published: February 10, 2025 by: The Motley Fool
Sentiment: Negative
On Monday, for the second time in as many business days, Illumina (ILMN -5.47%) stock took it on the chin because of an analyst recommendation downgrade. The biotech's shares closed the day almost 6% lower, during a session when the S&P 500 (^GSPC 0.67%) landed in the black with a 0.7% increase.
Read More
About Illumina, Inc. (ILMN)
- IPO Date 2000-07-28
- Website https://www.illumina.com
- Industry Medical - Diagnostics & Research
- CEO Jacob Thaysen
- Employees 8970